These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 17523196

  • 1. Asymmetric corticomotor excitability correlations in early Parkinson's disease.
    Wu AD, Petzinger GM, Lin CH, Kung M, Fisher B.
    Mov Disord; 2007 Aug 15; 22(11):1587-93. PubMed ID: 17523196
    [Abstract] [Full Text] [Related]

  • 2. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R.
    Brain; 2006 Apr 15; 129(Pt 4):1059-69. PubMed ID: 16476674
    [Abstract] [Full Text] [Related]

  • 3. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
    Rodrigues JP, Walters SE, Stell R, Mastaglia FL, Thickbroom GW.
    Neurosci Lett; 2008 Dec 19; 448(1):29-32. PubMed ID: 18952149
    [Abstract] [Full Text] [Related]

  • 4. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation.
    Lefaucheur JP.
    Clin Neurophysiol; 2005 Feb 19; 116(2):244-53. PubMed ID: 15661100
    [Abstract] [Full Text] [Related]

  • 5. Cortical inhibition in Parkinson's disease: new insights from early, untreated patients.
    Cantello R, Tarletti R, Varrasi C, Cecchin M, Monaco F.
    Neuroscience; 2007 Nov 30; 150(1):64-71. PubMed ID: 17964730
    [Abstract] [Full Text] [Related]

  • 6. Does the recruitment of excitation and inhibition in the motor cortex differ?
    Werhahn KJ, Behrang-Nia M, Bott MC, Klimpe S.
    J Clin Neurophysiol; 2007 Oct 30; 24(5):419-23. PubMed ID: 17912067
    [Abstract] [Full Text] [Related]

  • 7. Motor cortex reorganisation in Parkinson's disease.
    Thickbroom GW, Byrnes ML, Walters S, Stell R, Mastaglia FL.
    J Clin Neurosci; 2006 Jul 30; 13(6):639-42. PubMed ID: 16814549
    [Abstract] [Full Text] [Related]

  • 8. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C, Gorsler A, Bäumer T, Hidding U, Demiralay C, Hinkelmann K, Weiller C, Siebner HR, Münchau A.
    Brain; 2004 Dec 30; 127(Pt 12):2732-46. PubMed ID: 15509619
    [Abstract] [Full Text] [Related]

  • 9. Corticomotor excitability in drug-naive patients with Parkinson disease.
    Derejko M, Rakowicz M, Antczak J, Inglot E, Niewiadomska M.
    Neurol Neurochir Pol; 2013 Dec 30; 47(2):109-15. PubMed ID: 23649998
    [Abstract] [Full Text] [Related]

  • 10. Increased cortical excitability with longer duration of Parkinson's disease as evaluated by transcranial magnetic stimulation.
    Bhatia M, Johri S, Behari M.
    Neurol India; 2003 Mar 30; 51(1):13-5. PubMed ID: 12865507
    [Abstract] [Full Text] [Related]

  • 11. Altered corticomotor representation in patients with Parkinson's disease.
    Kagerer FA, Summers JJ, Byblow WD, Taylor B.
    Mov Disord; 2003 Aug 30; 18(8):919-27. PubMed ID: 12889083
    [Abstract] [Full Text] [Related]

  • 12. A motor cortex excitability and gait analysis on Parkinsonian patients.
    Vacherot F, Attarian S, Vaugoyeau M, Azulay JP.
    Mov Disord; 2010 Dec 15; 25(16):2747-55. PubMed ID: 20925071
    [Abstract] [Full Text] [Related]

  • 13. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T, Hidding U, Hamel W, Buhmann C, Moll CK, Gerloff C, Orth M, Siebner HR, Münchau A.
    Mov Disord; 2009 Apr 15; 24(5):672-6. PubMed ID: 19185021
    [Abstract] [Full Text] [Related]

  • 14. Implementation of the TMS in the early stages of Parkinson's disease.
    Guekht A, Selikhova M, Serkin G, Gusev E.
    Electromyogr Clin Neurophysiol; 2005 Apr 15; 45(5):291-7. PubMed ID: 16218197
    [Abstract] [Full Text] [Related]

  • 15. [Motor evoked potentials of transcranial magnetic stimulation for Parkinson's disease].
    Shimamoto H, Morimitsu H, Sugita S, Kimihiro N, Shigemori M, Kurihara Y.
    No To Shinkei; 1996 Sep 15; 48(9):825-9. PubMed ID: 8888031
    [Abstract] [Full Text] [Related]

  • 16. Reliability of intracortical and corticomotor excitability estimates obtained from the upper extremities in chronic stroke.
    Koski L, Lin JC, Wu AD, Winstein CJ.
    Neurosci Res; 2007 May 15; 58(1):19-31. PubMed ID: 17303273
    [Abstract] [Full Text] [Related]

  • 17. Short and long latency afferent inhibition in Parkinson's disease.
    Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R.
    Brain; 2003 Aug 15; 126(Pt 8):1883-94. PubMed ID: 12805105
    [Abstract] [Full Text] [Related]

  • 18. Transcranial magnetic stimulation reduces masseter motoneuron pool excitability throughout the cortical silent period.
    Sowman PF, Flavel SC, McShane CL, Miles TS, Nordstrom MA.
    Clin Neurophysiol; 2008 May 15; 119(5):1119-29. PubMed ID: 18313355
    [Abstract] [Full Text] [Related]

  • 19. Altered response to rTMS in patients with Alzheimer's disease.
    Inghilleri M, Conte A, Frasca V, Scaldaferri N, Gilio F, Santini M, Fabbrini G, Prencipe M, Berardelli A.
    Clin Neurophysiol; 2006 Jan 15; 117(1):103-9. PubMed ID: 16364684
    [Abstract] [Full Text] [Related]

  • 20. Cortical disinhibition in diabetic patients with neuropathic pain.
    Turgut N, Altun BU.
    Acta Neurol Scand; 2009 Dec 15; 120(6):383-8. PubMed ID: 19922582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.